Exelixis (EXEL) Share-based Compensation Growth (3y) (2013 - 2026)
Exelixis (EXEL) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 244.08% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -50.27% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 137.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 137.44% |
| Jan 2, 2026 | -39.66% |
| Oct 3, 2025 | 84.38% |
| Jul 4, 2025 | 87.52% |
| Apr 4, 2025 | 4.45% |
| Jan 3, 2025 | -52.19% |
| Jun 28, 2024 | 53.89% |
| Mar 29, 2024 | 52.01% |
| Dec 29, 2023 | -129.27% |
| Mar 31, 2023 | -43.24% |
| Sep 30, 2022 | 74.02% |
| Jul 1, 2022 | 5.22% |
| Apr 1, 2022 | 16.40% |
| Dec 31, 2021 | 71.78% |
| Jul 2, 2021 | -38.33% |
| Apr 2, 2021 | 36.72% |
| Jan 1, 2021 | -68.60% |
| Apr 3, 2020 | 108.48% |
| Sep 27, 2019 | 27.60% |
| Jun 28, 2019 | -40.73% |